【レポートの概要(一部)】
1 Introduction (Page No. – 25)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Markets Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders
2 Research Methodology (Page No. – 29)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.2.1 Key Data From Secondary Sources
2.2.2 Key Data From Primary Sources
2.2.2.1 Key Industry Insights
2.2.3 Assumptions
3 Executive Summary (Page No. – 37)
4 Premium Insights (Page No. – 43)
4.1 Molecular Diagnostics Market
4.2 Market,Infectious Diseases
4.3 Market, By Technology and Application
4.4 Market, By End User
4.5 Market, By Products and Services
5 Market Overview (Page No. – 47)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Prevalence Rate of Infectious Diseases and Various Types of Cancer
5.2.1.2 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
5.2.1.3 Development of Biomarker Identification and Advancements in Molecular Techniques
5.2.1.4 Growth in Proteomics and Genomics Research
5.2.1.5 Reforms in the Reimbursement System in the U.S.
5.2.2 Restraints
5.2.2.1 Molecular Diagnostic Tools With New and Complex Platforms Demand Skilled Labor and Mandatory Training
5.2.2.2 Complex Regulatory Framework to Delay Approvals of New Molecular Diagnostic Tests
5.2.3 Opportunities
5.2.3.1 Advances in Genomics
5.2.3.2 Significant Growth Prospects in Developing Countries
5.2.4 Challenge
5.2.4.1 Dearth of Trained Professionals Limiting the Appropriate Use of New Molecular Diagnostic Technologies
6 Molecular Diagnostics Market, By Application (Page No. – 56)
6.1 Introduction
6.2 Infectious Diseases
6.2.1 Hepatitis B
6.2.2 Hepatitis C
6.2.3 Human Immunodeficiency Virus (HIV)
6.2.4 Tuberculosis (TB)
6.2.5 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
6.2.6 Human Papillomavirus (HPV)
6.2.7 Methicillin-Resistant Staphylococcus Aureus (MRSA)
6.2.8 Others
6.3 Oncology
6.3.1 Prostate Cancer
6.3.2 Breast Cancer
6.4 Colorectal Cancer
6.5 Others
6.6 Genetic Tests
6.7 Blood Screening
6.8 Microbiology
6.9 Others
7 Molecular Diagnostics Market, By Technology (Page No. – 87)
7.1 Introduction
7.2 Polymerase Chain Reaction (PCR)
7.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
7.4 Microarrays
7.5 Hybridization (In-Situ Hybridization & Fish)
7.6 DNA Sequencing and Next-Generation Sequencing
7.7 Other Technologies
8 Molecular Diagnostics Market, By Products and Services (Page No. – 110)
8.1 Introduction
8.2 Reagents
8.3 Instruments
8.4 Software & Services
9 Molecular Diagnostics Market, By End User (Page No. – 124)
9.1 Introduction
9.2 Hospital/Academic Laboratories
9.3 Reference Laboratories
9.4 Other End Users
10 Molecular Diagnostic Market, By Region (Page No. – 136)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 U.K.
10.3.2 Germany
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe (RoE)
10.4 Asia
10.4.1 Japan
10.4.2 India
10.4.3 China
10.4.4 Rest of Asia (RoA)
10.5 Rest of the World (RoW)
10.5.1 Latin America
10.5.1.1 Mexico
10.5.1.2 Brazil
10.5.1.3 Rest of Latin America (RoLA)
10.5.2 Pacific Countries
10.5.3 Middle East & Africa
11 Competitive Landscape (Page No. – 192)
11.1 Overview
11.2 Market Share Analysis
11.3 Molecular Diagnostics Market Competitor Share Analysis, By Application
11.3.1 Market Share Analysis for Infectious Disease Diagnostics Applications
11.3.2 Market Share Analysis for Blood Screening Applications
11.3.3 Market Share Analysis for Microbiology Applications
11.3.4 Market Share Analysis for Oncology Applications
11.3.5 Market Share Analysis for Genetic Testing Applications
11.4 Molecular Diagnostics Market Share Analysis, By Technology
11.4.1 Polymerase Chain Reaction (PCR)
11.4.2 DNA Sequencing and Ngs
11.4.3 Microarray
11.4.4 Hybridization (In Situ and Fluorescence)
11.4.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
11.5 Product Approvals
11.6 Agreements, Collaborations, and Partnerships
11.7 New Product Launches
11.8 Acquisitions
11.9 Other Developments
12 Company Profiles (Page No. – 208)
12.1 Introduction
12.2 Abbott Laboratories
12.2.1 Business Overview
12.2.2 Abbott Laboratories: Company Snapshot
12.2.3 Products Offered
12.2.4 Recent Developments
12.2.5 MnM View
12.3 Qiagen N.V.
12.3.1 Business Overview
12.3.2 Qiagen N.V.: Company Snapshot
12.3.3 Products & Services Offered
12.3.4 Recent Developments
12.3.5 MnM View
12.4 Roche Diagnostics
12.4.1 Business Overview
12.4.2 Roche Diagnostics: Company Snapshot
12.4.3 Products Offered
12.4.4 Recent Developments
12.4.5 MnM View
12.5 Hologic, Inc.
12.5.1 Business Overview
12.5.2 Hologic, Inc.: Company Snapshot
12.5.3 Products Offered
12.5.4 Recent Developments
12.5.5 MnM View
12.6 Grifols
12.6.1 Business Overview
12.6.2 Grifols: Company Snapshot
12.6.3 Products Offered
12.6.4 Recent Developments
12.6.5 MnM View
12.7 Siemens Healthcare
12.7.1 Business Overview
12.7.2 Siemens Healthcare: Company Snapshot
12.7.3 Products Offered
12.7.4 Recent Developments
12.8 Becton, Dickinson and Company
12.8.1 Business Overview
12.8.2 Becton, Dickinson and Company: Company Snapshot
12.8.3 Products & Services Offered
12.8.4 Recent Developments
12.9 Beckman Coulter Inc. (Wholly Owned Subsidiary of Danaher Corporation)
12.9.1 Business Overview
12.9.2 Danaher Corporation: Company Snapshot
12.9.3 Products & Services Offered
12.9.4 Recent Developments
12.10 Biomérieux SA
12.10.1 Business Overview
12.10.2 Biomérieux: Company Snapshot
12.10.3 Products Offered
12.10.4 Recent Developments
12.11 Cepheid Inc.
12.11.1 Business Overview
12.11.2 Cepheid Inc.: Company Snapshot
12.11.3 Products Offered
12.11.4 Recent Developments
13 Appendix (Page No. – 263)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Other Developments
13.3.1 Abbott Laboratories
13.3.2 Qiagen N.V.
13.3.3 Roche Diagnostics
13.3.4 Hologic Inc.
13.3.5 Hologic Inc.
13.3.6 Siemens Healthcare
13.3.7 Becton, Dickinson and Company
13.3.8 Becton, Dickinson and Company
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports
【レポート販売概要】
■ タイトル:分子診断検査の世界市場:用途、技術(PCR、マイクロアレイ、DNAシークエンシング)、製品(試薬、装置、ソフトウェア)■ 英文:Molecular Diagnostics Market by Application (Infectious Disease (HIV, HPV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Microarray, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Software) - Forecast to 2020
■ 発行日:2015年11月16日
■ 調査会社:MarketsandMarkets
■ 商品コード:MAM-MD-2521
■ 調査対象地域:グローバル
- 高度教育用金融・HRMソフトウェアの世界市場2016-2020About the Higher Education Financial and HRM Software Market The global higher education financial and HRM software market consists of software solutions that are employed by institutions to improve the decision-making and productivity of employees and management of financial resources. The data collected from the software is further analyzed using analytics applications. The analysis is to ensure …
- エポキシプライマーの世界市場予測(~2023年)The increasing demand for epoxy primer in various applications and the growing awareness to reduce the loss caused by corrosion are expected to drive the growth of epoxy market. In terms of value, the global epoxy primer market is estimated to be USD 8.52 billion in 2018 and is projected to reach USD 10.91 billion by 2023, at a CAGR of 5.1% between 2018 and 2023. Based on substrate, the metal subs …
- 半導体検査装置の世界市場:ウェハ検査装置、マスク検査装置About Inspection Systems Inspection systems are part of fabrication equipment in the semiconductor device manufacturing process. These systems are used to find defects in masks and wafers during the production process of semiconductor wafers. The growing application of semiconductor ICs in segments like automobiles, consumer electronics, and industrial sector has compelled semiconductor ICs vendor …
- eGRCの世界市場:構成要素別(ソリューション、サービス)、展開モデル別(オンプレミス、クラウド)、組織規模別(大企業、中小企業)、ビジネス機能別(金融、情報技術、法務、運用)、種類別(方針管理、コンプライアンス管理、監査管理、インシデント管理、リスク管理、その他)、業種別(BFSI、IT&テレコム、小売、ヘルスケア、エネルギー&ユーティリティ、製造、政府&防衛、その他)Governance, risk, and compliance (GRC) refers to an organization-synchronized strategy for managing extensive issues of corporate compliance with regards to regulatory requirements, corporate governance, and enterprise risk management (ERM). It is a unified collection of capabilities, which enables organizations to reliably achieve objectives and act with integrity. GRC provides different strategi …
- BAY 94-9027 (Hemophilia A and B):市場予測と分析(~2022)BAY 94-9027 (Hemophilia A and B) - Forecast and Market Analysis to 2022 Summary The competitive landscape of hemophilia A and B recombinant therapy in the US and 5EU is dominated by the use of recombinant FVIII and FIX replacement factors, and patients with severe forms of the disease receive frequent prophylactic infusions beginning from the first one or two years of life and often continuing thr …
- BMS(ビル管理システム)の世界市場:HVAC制御、照明制御、セキュリティ・アクセス制御About BMS BMS are deployed in large buildings for the efficient energy management, and they help in controlling and managing building facilities such as lighting, electricity, fire precautions, safety, security, and HVAC. These systems are installed in buildings such as commercial buildings, IT parks, hotels, restaurants, manufacturing plants, retail outlets, and residential buildings for effectiv …
- 世界の地熱発電市場動向(2012-2016)TechNavio's analysts forecast the Global Geothermal Power Generation market to grow at a CAGR of 9.5 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing consumption of renewable energy. The Global Geothermal Power Generation market has also been witnessing increasing investments in R&D. However, the huge capital investment needed to constr …
- 2014 Assessments of Leading Hematology and Flow Cytometry Market Players–Strategic Analyses of Major Suppliers and Emerging Market EntrantsThis new report from Venture Planning Group provides strategic assessments of major suppliers of hematology and flow cytometry instuments and reagants, as well as emerging market entrants. The report presents strategic analyses of the major current and emerging suppliers in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative a …
- 電子タバコの世界市場2019-2023About this market The increasing availability of e-cigarette across various distribution channels will drive the e-cigarette market growth during the forecast period. Supermarkets chains across the globe have started offering e-cigarettes. In addition, vape shops in the US and the UK are also offering e-cigarettes to cater to the evolving end-user requirements of the end-users. As a result, severa …
- 世界のジオマーケティングソフトウェア市場:展開別、ロケーション別、地域別Global Geomarketing Software Market: About this market Technavio’s geomarketing software market analysis considers sales from both outdoor and indoor locations. Our study also finds the sales of geomarketing software in APAC, Europe MEA, North America, and South America. In 2019, the outdoor segment had a significant market share, and this trend is expected to continue over the forecast period. Fa …
- デジタルツインの世界市場予測(~2025年)“Digital twin market to grow at significant rate from 2019 to 2025” The digital twin market is estimated to grow from USD 3.8 billion in 2019 to USD 35.8 billion by 2025, at a CAGR of 37.8%. Key factors driving the growth of the digital twin market include the declining time and cost of product development and unplanned downtime with the adoption of digital twins, increasing adoption of emerging t …
- 装甲材料の世界市場:金属、合金、セラミック、複合材、パラアミド繊維、UHMWPE、ガラス繊維The armor materials market is projected to reach 10.54 Billion by 2020, registering a CAGR of 6.8% between 2015 and 2020. Changing battlefield scenarios and development of advanced weapons and ammunition are increasing the demand for better and effective armor solutions. Growth of the armor materials market can be attributed to increasing demand from vehicle, civil, and body armor applications. In …
- グローバルのICT投資動向:企業のIT支出パターンSummary Economic uncertainty and the need to adhere to stringent regulatory compliances are fuelling the adoption of disruptive technologies among retail banks. Retail banks are investing in agile ICT segments to streamline their operations and achieve greater efficiency to support their business growth Key Findings - Kable's survey shows that retail banks are continuously looking to increase thei …
- Tinnitus:グローバル臨床試験レビューH2, 2013Tinnitus Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Tinnitus Global Clinical Trials Review, H2, 2013" provides data on the Tinnitus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tinnitus. It includes an overview of the trial numbers and their recruitment status as per the site of trial condu …
- モノのインターネット(IoT)セキュリティの世界市場2016-2021Visiongain assesses that the global IoT Security market will reach $32,306.5m in 2021. It is therefore critical that your strategic planning is timely and your forecasting plans are in place to take advantage of the market. Visiongain’s 246 page report will ensure that you keep informed and ahead of your competitors. Gain that competitive advantage. The report will answer questions such as: • What …